Observational Prospective Study Describing the Global Patient Care and Follow-up of Prostate Cancer Patients Treated With Degarelix

NCT03193645 · clinicaltrials.gov ↗

COMPLETED

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Degarelix

Sponsor

Ferring Pharmaceuticals